Y Intercept Hong Kong Ltd Sells 59,312 Shares of Cognex Corporation $CGNX

Y Intercept Hong Kong Ltd reduced its holdings in shares of Cognex Corporation (NASDAQ:CGNX) by 90.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,290 shares of the scientific and technical instruments company’s stock after selling 59,312 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cognex were worth $285,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of CGNX. Quent Capital LLC acquired a new position in Cognex in the 3rd quarter valued at about $26,000. Geneos Wealth Management Inc. grew its position in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares during the last quarter. Penserra Capital Management LLC bought a new position in shares of Cognex during the second quarter worth approximately $29,000. TD Waterhouse Canada Inc. acquired a new stake in Cognex during the 2nd quarter worth approximately $29,000. Finally, First Horizon Corp bought a new stake in Cognex in the 3rd quarter valued at $38,000. 88.12% of the stock is owned by institutional investors.

Cognex Price Performance

NASDAQ CGNX opened at $39.49 on Friday. The business has a fifty day moving average price of $38.22 and a two-hundred day moving average price of $40.89. The stock has a market capitalization of $6.62 billion, a PE ratio of 61.70 and a beta of 1.53. Cognex Corporation has a fifty-two week low of $22.67 and a fifty-two week high of $49.76.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. JPMorgan Chase & Co. reiterated an “underweight” rating and set a $35.00 price objective (down previously from $45.00) on shares of Cognex in a research report on Wednesday, December 3rd. UBS Group reiterated a “buy” rating and issued a $58.00 price objective on shares of Cognex in a research note on Friday, October 31st. Robert W. Baird set a $45.00 price objective on shares of Cognex in a report on Friday, October 31st. Needham & Company LLC raised their target price on shares of Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a research report on Monday, December 29th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $45.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.